2
FDI World Dental Federation launches Consensus Statement on Sustainable Oral Healthcare / Paving the way for an industry Code of Good Practice
plus
Actualités sur Medicale
VIVOSENSE ANNOUNCES CLOSING OF $25M SERIES A FINANCING
Newport Beach (ots) - Proceeds to accelerate the collection and use of wearable sensor data in clinical trials along with the development of novel digital biomarkers Funding round co-led by the Perceptive Xontogeny Venture (PXV) Fund and Switzerland-based Debiopharm Innovation Fund VivoSense, Inc., (“VivoSense”) an agile end-to-end scientific solutions company developing novel digital endpoints from wearable sensor ...
plusLumanity Acquires Innovative Edge
New York (ots/PRNewswire) - Creating an end-to-end pharmaceutical product commercialization and launch excellence capability that optimizes and accelerates patient access to medical advances Lumanity today announced the acquisition of Innovative Edge ("IE"), a leading provider of pharmaceutical product launch services. The terms of the transaction were not disclosed. IE partners with world-leading biopharma companies – from Top 20 pharmaceutical manufacturers to ...
plusFDA approves CartiHeal's Implant for the Treatment of Cartilage and Osteochondral Defects
Kfar Saba, Israel (ots/PRNewswire) - Approval is based on results of a multicenter, randomized, open-labeled and controlled IDE clinical study that demonstrated the superiority of Agili-C™ implant to the current surgical standard of care, debridement and microfracture in the knee joint CartiHeal Ltd, developer of implants for the treatment of cartilage and ...
plusGrünenthal and NovaQuest enter agreement to advance the resiniferatoxin global Phase III program in osteoarthritis
Aachen, Germany, and Raleigh, North Carolina (ots) - Grünenthal and NovaQuest announced today that they have entered into an agreement to advance the global clinical Phase III programme of Grünenthal's asset resiniferatoxin (RTX). The investigational medicine is being developed with the aim of providing patients ...
plusAbcam the most awarded company at 2022 industry awards
Cambridge, England (ots/PRNewswire) - CAMBRIDGE, England, March 25, 2022 Abcam (AIM:ABC); (NASDAQ:ABCM), today announced that it has received six recognitions from CiteAb at their annual industry awards, the highest of any participant evaluated this year. This record number of acknowledgments follows a year of substantial investment for Abcam to enable life sciences researchers from academia and industry to advance ...
plus
Abcam the most awarded company at 2022 industry awards
Cambridge, England (ots/PRNewswire) - CAMBRIDGE, England, March 25, 2022 Abcam (AIM:ABC); (NASDAQ:ABCM), today announced that it has received six recognitions from CiteAb at their annual industry awards, the highest of any participant evaluated this year. This record number of acknowledgments follows a year of substantial investment for Abcam to enable life sciences researchers from academia and industry to advance ...
plusMoonLake Immunotherapeutics AG
MoonLake Immunotherapeutics to initiate global Phase 2 study of the Nanobody® Sonelokimab in patients with moderate-to-severe hidradenitis suppurativa with HiSCR75 as the primary endpoint
Zug, Switzerland (ots/PRNewswire) - - This Phase 2 study represents an important step in hidradenitis suppurativa ("HS") clinical development, as it will be the first to use the higher clinical response level of HiSCR75 as the primary endpoint - Expected to enroll over 200 patients with moderate-to-severe HS to ...
plusOPTEL Assists Glencore to Reduce Its GHG Emissions With Traceability
Quebec (ots/PRNewswire) - OPTEL, a leading global provider of supply chain traceability systems, has received a funding commitment of several million dollars from Sustainable Development Technology Canada (SDTC) to enable Glencore, one of the world's largest global natural resources companies, to adopt environmental traceability technologies. SDTC helps Canadian ...
plusIntroducing Lumanity - An Organization Dedicated to Accelerating and Optimizing Access to Medical Advances
New York and London (ots/PRNewswire) - Lumanity brings together a diverse collection of expert perspectives to uncover innovative yet pragmatic approaches to address the diverse and complex set of challenges associated with bringing medical advances to patients Today marks the launch of Lumanity, a company dedicated ...
plus- 2
FDI World Dental Federation asks how can industry drive innovation to improve oral health?
plus Zentiva to donate 100,000 packs of medicines to the Ukrainian Humanitarian Crisis
Prague (ots/PRNewswire) - Zentiva is a major developer and producer of high-quality and affordable medicines in Europe. Zentiva will donate 100,000 packs of medicines to humanitarian aid programs targeted at helping the citizens of Ukraine. The medicines will include life-saving hospital medicines, cardiovascular medicines, pain medication, and anti-infectives. The ...
plus
ECM Partners Inc. appoints Peter Prock as Chairman of FAMAR Group Board of Directors
Madrid (ots/PRNewswire) - FAMAR Group BoD also welcomes its new member Konstantinos Rengis ECM Partners Inc., FAMAR's major shareholder, announced today that Peter Prock is appointed as the new Chairman of the Board of Directors of FAMAR Group, a leading European contract development and manufacturing organization. "I am delighted to be joining FAMAR as Chairman at ...
plusJean-Luc Herbeaux to become Hovione CEO
Lisbon, Portugal (ots/PRNewswire) - Hovione today announced that the Board of Directors and the shareholders have approved the appointment of Dr. Jean-Luc Herbeaux as Hovione's Chief Executive Officer, effective 1st April 2022. Guy Villax, who has been Hovione's CEO for the past 25 years will now serve as a Member of the Board and shareholder. During his tenure, Hovione grew tenfold. The company currently employs 2000 ...
plusHovione and Zerion Pharma announce a strategic partnership to market the Dispersome® technology platform
Lisbon (ots/PRNewswire) - Hovione, the leader in spray drying and particle engineering, announced today a strategic partnership with Zerion Pharma to market and commercialize Dispersome®, Zerion´s proprietary solubility enhancement technology platform. Zerion´s innovative Dispersome® technology builds on a new ...
plus- 2
Exclusive Health & Safety Partner of the Munich Security Conference 2022: EcoCare commissioned to carry out daily COVID-19 tests on top politicians and diplomats
plus TytoCare Receives CE Mark Approval for its Lung Sounds Analyzer Providing Clinicians with AI-Powered Decision Support During Remote Examinations
New York (ots/PRNewswire) - The approval will aid European healthcare providers in clinically assessing lung sound data to determine whether wheezing is detected TytoCare, the global health care industry's first all-in-one modular device and examination platform for AI-powered, on-demand, remote medical exams, ...
plusDTx leader Sidekick announces key C-level hires in move to accelerate U.S. market growth
Boston, Reykjavik, Iceland and Berlin (ots/PRNewswire) - - UnitedHealth Group and Anthem veteran Pamela Stahl joins as Chief Commercial Officer (CCO) and President, North America to lead Sidekick's global commercial strategy, driving revenue growth with international pharmaceutical majors and U.S.-based payers. - Mitchell Mudra joins Sidekick from UnitedHealth Group as ...
plus
NanoPass's intradermal injection platform proven to sustain COVID-19 vaccine antibodies using 1/15 of the dose reports Chinese Institute of Medical Biology
Nes Ziona, Israel and Shanghai, China (ots/PRNewswire) - Intradermal COVID vaccination studies are emerging in a global effort to multiply available doses by harnessing skin immunity to reduce dosage required for effective vaccination. In a hallmark study published recently by IMB scientists[1], subjects were ...
plusIMTIS Holdings requests Turkcell Board to Call General Assembly of Shareholders to approve Board Changes and Proposals for Improved Corporate Governance
London (ots/PRNewswire) - - Turkcell has a weak governance regime - These problems have led to poor operating and strategic performance, low valuation and loss of investor confidence LetterOne, the holder of a 19.8% economic interest in Turkcell Iletisim Hizmetleri A.S. (the "Company" or "Turkcell") through its ...
plusPioneering research for non-invasive detection of cancer
Vienna / Baar (ots) - Scientists from the Swiss-Austrian research group HealthBiocare GmbH and System Biologie AG, in collaboration with the University of Vienna, have found a new non-invasive approach for the detection of the nine most common types of cancer. Although cancer is a leading cause of death worldwide, there are still no clinically approved tests for broader cancer screening of the population. The earlier ...
plus- 2
FDI World Dental Federation launches the Mouth Proud Challenge and asks how do you take care of your oral health?
plus DEBIOPHARM AND ASPEN PARTNER TO LAUNCH PROSTATE CANCER DRUG TRELSTAR® IN SOUTH AFRICA
Lausanne, Switzerland and Durban, South Africa (ots) - Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company and Aspen, a South African headquartered multinational pharmaceutical company announced today their partnership to launch Trelstar® (Triptorelin) in South Africa for the treatment of locally advanced and metastatic hormone dependent prostate ...
plusCyberMDX Healthcare Security Suite Release 5.0 Takes on the Ransomware Epidemic
New York (ots/PRNewswire) - Global Healthcare security leader introduces intelligent mitigation actioning into latest release - and launches two new offerings, including the industry's first IoT Security Freemium edition for healthcare organizations who need help now CyberMDX, a leading healthcare cybersecurity provider delivering visibility and threat prevention for ...
plus
Accord's SONDELBAY ®▼ (teriparatide) is given Green Light by CHMP
Harrow, England (ots/PRNewswire) - Sondelbay – is a self-administered, once-a-day subcutaneous injection for patients with osteoporosis using a pen device - Accord's fourth biosimilar, joins the company's established portfolio across Europe, and marks its first branded product in a new Bone Health franchise representing another great milestone in Accord's growing ...
plusMicreos appoints Joost Goderie as CFO and member of the Board of Directors
The Hague, The Netherlands (ots/PRNewswire) - Micreos announced that it has appointed Joost Goderie to the management board as Chief Financial Officer (CFO). Joost will be working closely together with the other members of the management team to help drive Micreos's growth and deliver its targeted antibacterial technology to the world. He will be responsible for ...
plusKLӦCKNER PENTAPLAST COMMITS TO rPET/PET CAPACITY EXPANSION FOR THE SUSTAINABLE HEALTHCARE AND FOOD PACKAGING MARKET IN NORTH AMERICA
London (ots/PRNewswire) - Klöckner Pentaplast (kp), a global leader in recycled content products and high-barrier protective packaging, has announced its intention to expand its post-consumer recycled content (PCR) PET capacity in North America with a significant investment to further grow its sustainable ...
plusNanoPass's intradermal delivery platform used in Emergex's next generation COVID-19 vaccination study
Nes Ziona, Israel (ots/PRNewswire) - Intradermal COVID-19 vaccination studies are emerging in a global effort to use available doses more effectively by harnessing skin immunity to reduce the dosage required for effective vaccination, as well as to improve the immunogenicity of weaker vaccines. Additionally, there ...
plusHearing loss company Acousia Therapeutics to present data for ACOU085 at ARO 2022 MidWinter Meeting February 5–9
Tübingen (ots) - Acousia Therapeutics GmbH – along with its partners from the Translational Hearing Research Group at the Tübingen Hearing Research Center (Department of Otolaryngology, Head and Neck Surgery, University of Tübingen) and Synovo GmbH (Tübingen) – will be presenting data on the the company’s ...
plusgenOway grants the leading UK academic research funder a non-exclusive license for CRISPR/Cas9 technology
Lyon, France (ots/PRNewswire) - genOway, a world leader in the field of genetically modified innovative research models, announced today that it has granted a non-exclusive CRISPR/Cas9 license to the most important funding institution of biomedical academic research in the United Kingdom. In December 2018, genOway ...
plus
Précédent567891011121314Suivant